0001140361-17-046688.txt : 20171219 0001140361-17-046688.hdr.sgml : 20171219 20171219144234 ACCESSION NUMBER: 0001140361-17-046688 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171215 FILED AS OF DATE: 20171219 DATE AS OF CHANGE: 20171219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KRIEGSMAN STEVEN A CENTRAL INDEX KEY: 0001197482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15327 FILM NUMBER: 171263737 MAIL ADDRESS: STREET 1: 2165 TECHNOLOGY DRIVE CITY: SCHENECTADY STATE: NY ZIP: 12308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTRX CORP CENTRAL INDEX KEY: 0000799698 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581642750 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 BUSINESS PHONE: 310-826-5648 MAIL ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 4 1 doc1.xml FORM 4 X0306 4 2017-12-15 0 0000799698 CYTRX CORP CYTR 0001197482 KRIEGSMAN STEVEN A 11726 SAN VICENTE BLVD. SUITE 650 LOS ANGELES CA 90049 1 1 0 1 CEO Chairman of the Board CytRx Common Stock 2017-12-15 4 A 0 387597 1.75 A 387597 D Stock Option (right to buy) 1.75 2017-12-15 4 A 0 208334 0 A 2027-12-14 CytRx Common Stock 208334 208334 D On December 6, 2017, the Compensation Committee of the Board of Directors agreed to award Mr. Kriegsman under the 2008 Equity Incentive Plan, 387,597 restricted common shares at the stock's closing prince on December 15, 2017 (the "award date"). The restricted shares will vest in equal installments on the first three anniversaries of the award date. The stock option vests monthly for 36 months in equal installments, beginning 15 January 2018, provided Reporting Person remains in continuous employ of Issuer, or the conditions for immediate vesting occur. STEVEN A. KRIEGSMAN 2017-12-19